France Herbal Medicine Market Size, Share, and COVID-19 Impact Analysis, By Intervention (Ayurveda, Apitherapy, Naturopathic Medicine, Traditional Chinese Medicine, Traditional Korean Medicine, and Others), By Product (Powder, Liquid/Gel, Tablets/Capsules, and Others), By Source (Barks, Leaves, Roots, and Others), and France Herbal Medicine Market Insights, Industry Trend, Forecasts to 2035

France Herbal Medicine Market Insights Forecasts to 2035

• The France Herbal Medicine Market Size Was Estimated at USD 5,998.9 Million in 2024
• The France Herbal Medicine Market Size is Expected to Grow at a CAGR of Around 26.2% from 2025 to 2035
• The France Herbal Medicine Market Size is Expected to Reach USD 77,541.9 Million by 2035

According to a research report published by Spherical Insights & Consulting, The France Herbal Medicine Market Size is anticipated to reach USD 77,541.9 Million by 2035, Growing at a CAGR of 26.2% from 2025 to 2035. The France herbal medicine market is driven by growing consumer preference for natural and plant-based treatments, rising awareness of preventive healthcare, increasing trust in traditional and alternative medicine, and concerns over the side effects of synthetic drugs. Supportive regulations and strong retail availability further boost market growth.

Market Overview

The France herbal medicine market encompasses the development, production, distribution, and consumption of plant-derived medicinal products. These are products capable of preventing, managing, or satisfying the treatment of various health conditions. Products that only consider phytopharmaceuticals, standardized herbal extracts, tinctures, capsules, tablets, teas, syrups, and topical formulations have been found to be the most common for the treatment of conditions like digestive disorders, respiratory illnesses, stress and anxiety, sleep disturbances, immune support, and musculoskeletal problems. Herbal medicines in France come in the form of over-the-counter products or prescribed phytotherapy treatments, which are mostly a matter of formulation and regulatory classification. The market is driven by the changes in consumer lifestyle to a preference for natural and organic treatments, the awareness of preventive healthcare, the growing rate of lifestyle diseases, and the fear of the side effects of synthetic drugs.

Herbal medicine and plant-based remedies take precedence in the France market, as consumers in France are increasingly offering natural alternatives or natural complements to conventional drugs. Through studies, around 64-68% of the French people reportedly prefer natural remedies and have switched at least one of their conventional medicines to an herbal product. The change has been even more prominent with young adults. The product market for plant-based health, which includes phytotherapy and herbal supplements, has witnessed huge growth. In 2024, its value was estimated at approximately USD 5,998.9 million and is projected to hit almost USD 77,541.9 million in 2035. This boom represents a diverse range of consumers who are looking at plant-based solutions to help them with chronic discomforts, digestive problems, and stress, and bring about wellness, thus moving their reliance from only conventional medicines.

Government regulation and policy frameworks in France serve to strengthen the herbal medicine ecosystem, among other things, by ensuring quality and safety, which is achieved through the supervision of agencies like ANSES as well as by regulating product labeling and cultivation practices to protect consumers. Indeed, the government does not have a large research fund solely dedicated to herbal medicine; however, public policies on nutraceutical safety and product efficacy standards help build consumer trust and support responsible market growth. France is also one of the biggest markets in Europe for plant-based supplements, contributing to the €2.7 billion food supplement sector and thus reflecting a wide consumer acceptance of botanical health products.

Report Coverage

This research report categorizes the market for the France herbal medicine market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France herbal medicine market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France herbal medicine market.

Driving Factors

The France herbal medicine market is mainly driven by the preference of people towards natural and plant-based treatments, the awareness that has been created about the side effects of chemical drugs, and the increasing adoption of herbal remedies for common health issues such as stress, digestion, and immunity. The market growth is also supported by the fact that these products are easily accessible through pharmacies and online stores.

Restraining Factors

The France herbal medicine market is restrained by several issues, such as strict regulatory controls, insufficient clinical trials of some herbal products, and intense rivalry with conventional pharmaceuticals. Moreover, the advent of varied product quality, no standardization, and doubts of some practitioners further hinder the adoption at the wider level.

Market Segmentation

The France herbal medicine market share is classified into intervention, product, and source.

• The ayurveda segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France herbal medicine market is segmented by intervention into ayurveda, apitherapy, naturopathic medicine, traditional Chinese medicine, traditional Korean medicine, and others. Among these, the ayurveda segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The ayurveda segment is growing because of rising consumer preference for natural and holistic therapies, increasing awareness of herbal and plant-based therapies, and growing demand for alternative treatments for chronic lifestyle disorders. Expanding availability of Ayurvedic products through pharmacies and wellness centers, along with trust in traditional healing systems, further supports segment growth.

• The tablets/capsules segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The France herbal medicine market is segmented by product into powder, liquid/gel, tablets/capsules, and others. Among these, the tablets/capsules segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The tablets/capsules segment is growing because it offers convenience, precise dosage, longer shelf life, and ease of consumption compared to other forms. Strong consumer preference for standardized, easy-to-use herbal products and wide availability through pharmacies and online channels further drive growth in France.

• The roots segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France herbal medicine market is segmented by source into barks, leaves, roots, and others. Among these, the roots segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The roots segment is growing because roots are rich in concentrated bioactive compounds and are widely used in traditional systems like Ayurveda and Traditional Chinese Medicine. Their proven effectiveness in immunity, digestion, and chronic condition management, along with the rising demand for natural therapies in France, supports strong market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France herbal medicine market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Arkopharma
• Laboratoires Boiron
• Phyto­Pharma
• Laboratoires Lehning
• Laboratoires Arkocaps
• Horphag Research (Pycnogenol producer)
• Naturex (Givaudan)
• Biover
• Weleda France
• L’Herbier de France
• Laboratoires Granions
• Laboratoires Naturactive
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France herbal medicine market based on the below-mentioned segments:

France Herbal Medicine Market, By Intervention

• Ayurveda
• Apitherapy
• Naturopathic Medicine
• Traditional Chinese Medicine
• Traditional Korean Medicine
• Others

France Herbal Medicine Market, By Product

• Powder
• Liquid/Gel
• Tablets/Capsules
• Others

France Herbal Medicine Market, By Source

• Barks
• Leaves
• Roots
• Others